Drug recall · July 15, 2020
Brimonidine Tartrate Opthalmic Solution 0.2% recall
Why: Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Brimonidine Tartrate Opthalmic Solution 0.2%, 10 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-232-01
- Lots / codes
Lots # BRM12W9001, EXP 2020; BRM12W9002, BRM12W9003, EXP Dec. 2020; BRM12W9004, EXP Apr. 2021
- Quantity
- 48,852 bottles
- Company
- Somerset Therapeutics LLC, Somerset, NJ
- Distribution
- Nationwide
- Initiated
- June 4, 2020 · Voluntary: Firm initiated
- Classified
- July 7, 2020
- Reported
- July 15, 2020
- Ended
- June 30, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Brimonidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.